packageVemurafenib

vemurafenib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Vemurafenib is a BRAF inhibitor used to treat melanoma, including metastatic melanoma, and has also been used for skin cancer, hairy cell leukemia, and Erdheim-Chester disease. It is an approved medicine, authorised in the European Union for melanoma, and is also being investigated for other uses.

Summary written by glm-5.3-flash from Wikidata Q423111 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:vemurafenib
ATC codes:L01EC01
DrugBank:DB08881
PubChem CID:42611257
ChEBI:63637
Wikidata:Q423111
formula:C23H18ClF2N3O3S
molar mass:489.921 g/mol (PubChem CID 42611257)
logP:5 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown